Advertisement

Platelet-rich plasma in treatment of patients with idiopathic carpal tunnel syndrome

  • Mohammad K. Senna
  • Reham M. ShaatEmail author
  • Alaa Ali Awad Ali
Original Article

Abstract

Background

Carpal tunnel syndrome (CTS) is the most common entrapment neuropathy in the upper extremity. Treatments for CTS alternate from conservative strategies to surgical decompression of median nerve. Few studies have applied platelet-rich plasma (PRP) for treating idiopathic CTS, with acceptable success rates. Further studies are needed to reach concrete conclusion.

Objective

To study the effect of PRP injection in treatment of mild to moderate idiopathic CTS.

Methods

This is a randomized controlled trial in a cohort of Egyptian patients suffered from mild to moderate CTS. They were randomly divided into two groups. Group 1: patients received ultrasound guided PRP injection and group 2 patients received ultrasound guided corticosteroid injection. The outcome measures were assessed via Visual Analog Scale, the Boston Carpal Tunnel Syndrome Questionnaire, electrophysiological findings in sensory and motor functions of median nerve and morphological changes of median nerve detected by ultrasound.

Results

This study included 150 patients suffered from mild to moderate idiopathic CTS 15 did not provide the written consent and 37 participants were excluded from the study based on the exclusion criteria leaving only 98 patients to participate in the study they were divided into two groups PRP Injection Group (PRP-inj-G) — this group included 49 patients (40 females and 9 males) steroid injection Group (St-inj-G) — included 49 patients (41 females and 8 males). At the beginning of study there was no significant difference between both groups in all parameters. (a) PRP injection had significantly improved the clinical manifestations, the electrodiagnostic examination (EDX) parameters of the median nerve (MN), and the median nerve cross sectional area (m-CSA) at 1 month and 3 months post-injection evaluation in comparison to baseline recordings; (b) local steroid injection had significantly improved the clinical manifestations, the EDX parameters of the MN, and the m-CSA at 1 month and 3 months post-injection evaluation in comparison to baseline recordings and (c) PRP injection was superior to the local steroid injection in the improvement of clinical manifestations as well as the MN motor conduction velocity along the wrist-elbow segment, the sensory latency (SL) and the MN sensory conduction, this superiority was observed in third month follow-up suggesting better outcomes in long-term follow-up.

Conclusion

Platelet-rich plasma could be effective treatment of mild to moderate idiopathic CTS and superior to corticosteroid in improving pain, function, and distal sensory latency of median nerve.

Trial registration

Clinical Trials.gov Identifier: NCT03863873

Key Points:

PRP is effective treatment of mild to moderate CTS.

PRP is superior to corticosteroids in improving pain and function in CTS.

Keywords

Carpal tunnel syndrome Corticosteroids Platelet rich plasma 

Abbreviations

APBm

Abductor pollicis brevis muscle

BCTQ

Boston carpal tunnel questionnaire

BCTQ-FSS

Boston carpal tunnel questionnaire functional status scale

BCTQ-SSS

Boston carpal tunnel questionnaire symptom severity scale

CTS

Carpal tunnel syndrome

CMAP

Compound muscle action potential

DML

Distal motor latency

EDX

Electrodiagnosis

GFs

Growth factors

ICTS

Idiopathic carpal tunnel syndrome

Inj.G

Injection group

m.CSA

Median cross sectional area

MN

Median nerve

PRP

Platelet rich plasma

RCT

Randomized controlled trial

SNAP

Sensory nerve action potential

SNCV

Sensory nerve conduction velocity

SL

Sensory latency

VAS

Visual analog scale

Notes

Acknowledgments

All authors wish to express deep appreciation and gratitude to professor Mohammad K. for his support in statistical analysis of this work and great appreciation to all cooperative patients participated in this study.

Author contributions

All authors have contributed to the concept and design of the study, interpretation of the data and revising the manuscript, and have approved the final draft.

Dr. Mohammad k. Senna assessed EDX outcomes, Dr. Reham M. assessed US outcome and Dr. Alaa assessed clinical outcomes.

Funding

This study was totally funded by all authors. All authors are responsible for payment of publications fees. All authors declare that they did not receive any financial support.

Compliance with ethical standards

Disclosures

None.

References

  1. 1.
    Shiri R, Miranda H, Heliövaara M, Viikari-Juntura E (2009) Physical work load factors and carpal tunnel syndrome: a population-based study. Occup Environ Med 66(6):368–373CrossRefGoogle Scholar
  2. 2.
    O'Connor D, Marshall S, Massy-Westropp N.(2003) Non-surgical treatment (other than steroid injection) for carpal tunnel syndrome. Cochrane Database Syst Rev;(1):CD003219. ReviewGoogle Scholar
  3. 3.
    Katz JN, Keller RB, Simmons BP, Rogers WD, Bessette L, Fossel AH et al (1998) Maine carpal tunnel study: outcomes of operative and nonoperative therapy for carpal tunnel syndrome in a community-based cohort. J Hand Surg [Am] 23(4):697–710CrossRefGoogle Scholar
  4. 4.
    Gerritsen AA, Korthals-de Bos IB, Laboyrie PM, de Vet HC, Scholten RJ, Bouter LM (2003) Splinting for carpal tunnel syndrome: prognostic indicators of success. J Neurol Neurosurg Psychiatry 74(9):1342–1344CrossRefGoogle Scholar
  5. 5.
    Huisstede BM, Hoogvliet P, Randsdorp MS, Glerum S, van Middelkoop M, Koes BW (2010) Carpal tunnel syndrome. Part I: effectiveness of nonsurgical treatments--a systematic review. Arch Phys Med Rehabil 91(7):981–1004CrossRefGoogle Scholar
  6. 6.
    Marshall S, Tardif G, Ashworth N(2007) "Local corticosteroid injection for carpal tunnel syndrome." Cochrane Database Syst Rev;(2):Cd001554Google Scholar
  7. 7.
    Sampson S, Gerhardt M, Mandelbaum B (2008) Platelet rich plasma injection grafts for musculoskeletal injuries: a review. Curr Rev Musculoskelet Med 1(3–4):165–174CrossRefGoogle Scholar
  8. 8.
    Zheng C, Zhu Q, Liu X, Huang X, He C, etal JL (2016) Effect of platelet-rich plasma (PRP) concentration on proliferation, neurotrophic function and migration of Schwann cells in vitro. J Tissue Eng Regen Med 10(5):428–436CrossRefGoogle Scholar
  9. 9.
    Uzun H, Bitik O, Uzun Ö, Ersoy US, Aktaş E (2016) Platelet-rich plasma versus corticosteroid injections for carpal tunnel syndrome. J Plast Surg Hand Surg 51(5):301–305 1–5CrossRefGoogle Scholar
  10. 10.
    You H, Simmons Z, Freivalds A, Kothari MJ, Naidu SH (1999) Relationships between clinical symptom severity scales and nerve conduction measures in CTS. Muscle Nerve 22:497–501CrossRefGoogle Scholar
  11. 11.
    Werner RA, Andary M (2011) Electrodiagnostic evaluation of carpal tunnel syndrome. Muscle Nerve 44(4):597–607CrossRefGoogle Scholar
  12. 12.
    Padua L, Lo Monaco M, Valente EM, Tonali PA (1996) A useful electrophysiologic parameter for diagnosis of carpal tunnel syndrome. Muscle Nerve 19(1):48–53CrossRefGoogle Scholar
  13. 13.
    Wong SM, Griffith JF, Hui AC, Tang A, Wong KS (2002) Discriminatory sonographic criteria for the diagnosis of carpal tunnel syndrome. Arthritis Rheum 46(7):1914–1921CrossRefGoogle Scholar
  14. 14.
    Miyamoto H, Halpern EJ, Kastlunger M, Gabl M, Arora R, Bellmann-Weiler R, Feuchtner GM, Jaschke WR, Klauser AS (2014) Carpal tunnel syndrome: diagnosis by means of median nerve elasticity--improved diagnostic accuracy of US with sonoelastography. Radiology. 270(2):481–486CrossRefGoogle Scholar
  15. 15.
    Dhurat R, Sukesh M (2014) Principles and methods of preparation of platelet-rich plasma: a review and author’s perspective. J Cutan Aesthet Surg 7(4):189–197CrossRefGoogle Scholar
  16. 16.
    Wu YT, Ho TY, Chou YC, Ke MJ, Li TY, Huang GS, Chen LC (2017) Six-month efficacy of platelet-rich plasma for carpal tunnel syndrome: a prospective randomized, single-blind controlled trial. Sci Rep 7(1):94CrossRefGoogle Scholar
  17. 17.
    Lee JY, Park Y, Park KD, Lee JK, Lim OK (2014) Effectiveness of ultrasound-guided carpal tunnel injection using in-plane ulnar approach: a prospective, randomized, single-blinded study. Medicine (Baltimore) 93(29):e350CrossRefGoogle Scholar
  18. 18.
    Jensen MP, Karoly P, Braver S (1986) The measurement of clinical pain intensity: a comparison of six methods. Pain. 27:117–126CrossRefGoogle Scholar
  19. 19.
    Leite JC, Jerosch-Herold C, Song F (2006) A systematic review of the psychometric properties of the Boston Carpal Tunnel Questionnaire. BMC Musculoskelet Disord 7:78CrossRefGoogle Scholar
  20. 20.
    Simovic D, Weinberg DH (1999) The median nerve terminal latency index in carpal tunnel syndrome: a clinical case selection study. Muscle Nerve 22:573–577CrossRefGoogle Scholar
  21. 21.
    Macdonell RA, Schwartz MS, Swash M (1990) Carpal tunnel syndrome: which finger should be tested? An analysis of sensory conduction in digital branches of the median nerve. Muscle Nerve 13:601–606CrossRefGoogle Scholar
  22. 22.
    Buchberger W, Judmaier W, Birbamer G, Lener M, Schmidauer C (1992) Carpal tunnel syndrome: diagnosis with high-resolution sonography. AJR Am J Roentgenol 159:793–798CrossRefGoogle Scholar
  23. 23.
    Sánchez M, Anitua E, Delgado D, Prado R, Sánchez P, Fiz N et al (2017) Ultrasound-guided plasma rich in growth factors injections and scaffolds hasten motor nerve functional recovery in an ovine model of nerve crush injury. J Tissue Eng Regen Med 11(5):1619–1629CrossRefGoogle Scholar
  24. 24.
    Piskin A, Kaplan S, Aktaş A, Ayyildiz M, Raimondo S, Aliç T (2009) Platelet gel does not improve peripheral nerve regeneration: an electrophysiological, stereological, and electron microscopic study. Microsurgery 29(2):144–153CrossRefGoogle Scholar
  25. 25.
    Malahias MA, Johnson EO, Babis GC, Nikolaou VS (2015) Single injection of platelet-rich plasma as a novel treatment of carpal tunnel syndrome. Neural Regen Res 10(11):1856–1859CrossRefGoogle Scholar
  26. 26.
    Atwaa ET, Esh AM, Abd El Al IT, Awad YM (2018) Platelet-rich plasma versus corticosteroid injections for carpal tunnel syndrome: clinical and electrophysiological study. Egypt Rheumatolt 41(3):237–241CrossRefGoogle Scholar
  27. 27.
    Uzun H, Bitik O, Uzun Ö, Ersoy US, Aktaş E (2017) Platelet-rich plasma versus corticosteroid injections for carpal tunnel syndrome. J Plast Surg Hand Surg 51(5):301–305CrossRefGoogle Scholar
  28. 28.
    Raeissadat SA, Karimzadeh A, Hashemi M, Bagherzadeh L (2018) Safety. Efficacy of platelet-rich plasma in treatment of carpal tunnel syndrome; a randomized controlled trial. BMC Musculoskelet Disord 19(1):49CrossRefGoogle Scholar
  29. 29.
    Agarwal V, Singh R, Sachdev A, Wiclaff, Shekhar S, Goel DA (2005) Prospective study of the long-term efficacy of local methyl prednisolone acetate injection in the management of mild carpal tunnel syndrome. Rheumatology (Oxford) 44(5):647–650CrossRefGoogle Scholar
  30. 30.
    Peters-Veluthamaningal C, Winters JC, Groenier KH, Meyboom-de Jong B (2010) Randomised controlled trial of local corticosteroid injections for carpal tunnel syndrome in general practice. BMC Fam Pract 29(11):54CrossRefGoogle Scholar
  31. 31.
    El-Badawy M (2015) Electrophysiological and clinical comparison of local steroid injection by means of proximal versus distal approach in patients with mild and moderate carpal tunnel syndrome. Egypt Rheumatol Rehabil 42(3):120–127CrossRefGoogle Scholar
  32. 32.
    Soyupek F, Yesildag A, Kutluhan S, Askin A, Ozden A, etal UGA (2012) Determining the effectiveness of various treatment modalities in carpal tunnel syndrome by ultrasonography and comparing ultrasonographic findings with other outcomes. Rheumatol Int 32(10):3229–3234CrossRefGoogle Scholar
  33. 33.
    Wu YT, Ke MJ, Chou YC, Chang CY, Lin CY, Li TY (2016) Effect of radial shock wave therapy for carpal tunnel syndrome: a prospective randomized, double-blind, placebo-controlled trial. J Orthop Res 34(6):977–984CrossRefGoogle Scholar
  34. 34.
    Sánchez M, Garate A, Delgado D, Padilla S (2017) Platelet-rich plasma, an adjuvant biological therapy to assist peripheral nerve repair. Neural Regen Res 12(1):47–52CrossRefGoogle Scholar

Copyright information

© International League of Associations for Rheumatology (ILAR) 2019

Authors and Affiliations

  1. 1.Faculty of Medicine, Department of Rheumatology and RehabilitationMansoura UniversityMansouraEgypt

Personalised recommendations